New Harbor Capital Invests in Monroe Biomedical Research

August 30, 2023

New Harbor Capital has completed a growth investment in Monroe Biomedical Research (MBR), a clinical trial site business headquartered in Monroe, North Carolina. New Harbor will partner with MBR's founder-led team to scale the company's multi-site clinical research capabilities and expand its patient recruitment and trial execution capacity.

Buyers
New Harbor Capital
Targets
Monroe Biomedical Research
Location
North Carolina, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.